8th Oncolytic Virotherapy Summit 2023 Revere Hotel Boston Common, Boston

Event Starts In

Welcome to the 8th Oncolytic Virotherapy Summit: Engineering Oncolytic Viruses Towards Revolutionary Anti-Cancer Immunotherapies

Recent years have seen highly promising and rapid advances in the pre-clinical development and clinical evolution of oncolytic virotherapies. They are increasingly being recognised as a therapy with huge potential to change the landscape for cancer immunotherapy. In the past 3 months alone, we have witnessed 20 new drugs entering into pre-clinical and clinical phases, and exciting FDA Fast Track Designation for Candel Therapeutics OV candidate – this community continues to maximize the impact of these hopeful therapies.

Unite with 100+ OV trailblazers across sessions spanning Early Discovery, Translation, Clinical Development, Chemistry, Manufacturing and Controls (CMC) and Regulations to overcome the industry’s largest and critical bottlenecks. Meet your community to hear how they address the major challenges facing the industry:

Investigate the Manufacturing Challenges and Approaches to Produce a Successful Oncolytic Virus to Ensure its Quality, Traceability, and Reliability
Understand the raw materials and supply chain management of your oncolytic virus and, explore the importance of stability of your viral vectors with insights from VYRIAD and Circio Bio

⌛ Event Dates & Venue

12 Dec - 14 Dec 2023, 9:00 am - 6:00 pm

💸 Website & Tickets

Go to Event Website
Ticket Pricing:
Drug Developer Pricing | Conference + Focus Day: USD 4297.00, Drug Developer Pricing | Conference Only: USD 2999.00, Academic Pricing | Conference + Focus Day: USD 3697.00, Academic Pricing | Conference Only: USD 2599.00, Solution and Service Provider Pricing | Conference + Focus Day: USD 5297.00, Solution and Service Provider Pricing | Conference Only: USD 3799.00

◑ Topics | Categories